Changes in the total MRI inflammation score are associated with changes in clinical disease activity in RA patients who are escalating therapy in a Treat-to-Target (T2T) regimen
JavaScript is disabled for your browser. Some features of this site may not work without it.
Changes in the total MRI inflammation score are associated with changes in clinical disease activity in RA patients who are escalating therapy in a Treat-to-Target (T2T) regimen
Reference:New Zealand Rheumatology Association and Australian Rheumatology Association with the Rheumatology Health Professionals Association Joint Annual Scientific Meeting, Auckland, New Zealand, 20 May 2017 - 23 May 2017. Internal Medicine Journal: Special Issue. Wiley. 47: 8-9. May 2017